
PhaseV Secures $50 Million in Funding for AI-Driven Clinical Trial Solutions
PhaseV secures $50 million for AI-driven clinical trial solutions, enhancing efficiency in biopharma and CRO operations. π°π€
Discover the newest research about AI innovations in π§ Digital Therapeutics.

PhaseV secures $50 million for AI-driven clinical trial solutions, enhancing efficiency in biopharma and CRO operations. π°π€

“Digital Health Curriculum Boosts Student Competence π: 65% Women, 1.8 Mean Increase in Robotics Skills!” π€

AI predicts pediatric brain cancer relapse with 75-89% accuracy, improving care for children with gliomas. π§ π

TSOLife raises $43 million for its AI platform, Minerva, enhancing senior living through data-driven insights and community connections. π‘π

iPiDA-LGE enhances piRNA-disease association detection using local and global graph learning. ππ¬ Improved predictive performance noted!

Cedars-Sinai and Redesign Health are collaborating on a digital health initiative to enhance patient care and operational efficiency. π₯π»
AI-powered medical devices are enhancing healthcare delivery through early disease detection and real-time monitoring. π©Ίπ

EMC Healthcare in Indonesia is upgrading to an AI-driven EMR system, enhancing patient care and clinical efficiency. π₯π€

Atropos Health partners with Ontada to enhance oncology data use, improving patient care and treatment protocols. ππ

Revolutionizing Vital Sign Monitoring: Comestai App’s Non-contact Methodology π±π